Paola Francalanci

Paola Francalanci

Auto-generated profile, based on publicly available information

Paola Francalanci

Department of Pathology, Bambino Gesù Children's Hospital, Rome, Italy

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2003 in American Journal of Surgical Pathology
Verified
Journal Article
Closed access
PFPaola Francalanci
Paola Francalanci
FDFrancesca Diomedi-Camassei
Francesca Diomedi-Camassei
CPCristina Purificato
Cristina Purificato
FSFilippo Maria Santorelli
Filippo Maria Santorelli
AGAldo Giannotti
Aldo Giannotti
RBRenata Boldrini
Renata Boldrini
Tuberous sclerosis complex (TSC) is an autosomal dominant condition whose signs and symptoms may vary from a few hypopigmented skin spots to epilepsy, severe mental retardation, and renal failure. The disease is caused by mutations in either TSC1 or TSC2 gene, at chromosome 9q34 and 16p13.3. Inactivation of both alleles at TSC1 or TSC2 loci is associated with the development of hamartomas in different organs, and only rarely with malignant neoplasms. In this study we present a 6-year-old boy with TSC and with a malignant islet cell tumor of the pancreas. Mutation analysis of DNA extracted from peripheral blood cells of the patient identified an R1459X de novo mutation in exon 33 of the TSC2 gene. Immunohistochemical analysis with anti-tuberin antibodies on paraffin-embedded tissue sections showed loss of tuberin immunostaining in tumor cells but normal expression in residual normal pancreas. DNA analysis of tumor and normal cells showed chromosome 16p13 loss of heterozygosity in malignant pancreatic islet cell tumor but not in normal pancreas. These findings suggest a role for tuberin, the TSC2 gene product, in the pathogenesis of malignant pancreatic endocrine tumor.

15 November 2012 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
CSCaecilia Sukowati
Caecilia Sukowati
NRNatalia Rosso
Natalia Rosso
DPDevis Pascut
Devis Pascut
BABeatrice Anfuso
Beatrice Anfuso
GTGiuliano Torre
Giuliano Torre
CTClaudio Tiribelli
Claudio Tiribelli
The Breast Cancer Resistance Protein (BCRP/ABCG2) is one member of ABC transporters proteins super family responsible of drug resistance. Since data on ABCG2 expression in liver malignances are scanty, here we report the expression of ABCG2 in adult human hepatocellular carcinoma (HCC) in both in vivo and in vitro models with different degree of malignancy.

1 January 2008 in Digestion
Verified
Journal Article
Closed access
PFPaola Francalanci
Paola Francalanci
PAPaola De Angelis
Paola De Angelis
FMFrancesca Minnei
Francesca Minnei
FCFrancesca Diomedi Camassei
Francesca Diomedi Camassei
FTFilippo Torroni
Filippo Torroni
FCFrancesco Callea
Francesco Callea
Background: Esophageal diseases are common in infants and children, and may present with several clinical and pathological aspects. Eosinophilic esophagitis (EE) is characterized by inflammatory, predominantly eosinophilic infiltrate (≧15 eosinophils per high-power field (HPF)) that is not responsive to acid suppression therapy. An immunoallergic pathogenesis has been hypothesized, likely related to food allergy. Barrett’s esophagus (BE) is due to chronic gastroesophageal reflux. The pathological consequence is the replacement of normal stratified squamous epithelium by columnar mucosa with goblet cells. Methods: We present 2 children with a history of food allergy. Endoscopy revealed linear furrows and yellow plaques in the mid-distal esophagus. Results: In both patients histology showed a high number of eosinophils (>30 at HPF) in the mid-distal esophagus and intestinal metaplasia with goblet cells in distal esophagus. Diagnosis of EE associated to BE was made. Restriction diet was administered to treat EE whereas, in 1 case, laparoscopic fundoplication was performed to treat BE. Follow-up showed a remission of endoscopic and histological aspects. Conclusions: The unusual, possibly fortuitous association of EE and BE, two conditions differing in etiopathogenesis, clinical and pathological features, calls for a correct diagnosis to offer suitable treatment and prognosis.

14 March 2003 in Medical and Pediatric Oncology
Verified
Journal Article
Closed access
PDF file
FCFrancesca Diomedi Camassei
Francesca Diomedi Camassei
AJAlessandro Jenkner
Alessandro Jenkner
LRLucilla Ravà
Lucilla Ravà
CBCesare Bosman
Cesare Bosman
PFPaola Francalanci
Paola Francalanci
RBRenata Boldrini
Renata Boldrini

1 October 2009 in Liver International
Verified
Journal Article
Closed access
PDF file
PFPaola Francalanci
Paola Francalanci
FSFilippo M. Santorelli
Filippo M. Santorelli
SSSimona Saccani
Simona Saccani
MBMaria F. Bonetti
Maria F. Bonetti
DMDaniela Medicina
Daniela Medicina
FCFrancesco Callea
Francesco Callea

17 February 2006 in The American Journal of Cardiology
Verified
Journal Article
Closed access
PDF file
PFPaola Francalanci
Paola Francalanci
FCFrancesca Diomedi Camassei
Francesca Diomedi Camassei
MOMarcello Orzalesi
Marcello Orzalesi
ODOlivier Danhaive
Olivier Danhaive
FCFrancesco Callea
Francesco Callea